Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
89.00
+0.22 (0.25%)
At close: Oct 25, 2024, 4:00 PM
88.93
-0.07 (-0.08%)
After-hours: Oct 25, 2024, 5:43 PM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 86.95, with a low estimate of 69 and a high estimate of 105. The average target predicts a decrease of -2.30% from the current stock price of 89.00.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GILD stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 3 | 2 | 3 | 3 | 4 | 8 |
| Hold | 10 | 11 | 11 | 11 | 11 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 17 | 17 | 17 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $74 → $96 | Hold → Buy | Upgrades | $74 → $96 | +7.87% | Oct 21, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $85 → $94 | Buy | Maintains | $85 → $94 | +5.62% | Oct 17, 2024 |
| Bernstein | Bernstein | Buy Initiates $105 | Buy | Initiates | $105 | +17.98% | Oct 17, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $95 → $100 | Buy | Maintains | $95 → $100 | +12.36% | Oct 9, 2024 |
| Barclays | Barclays | Hold Maintains $76 → $84 | Hold | Maintains | $76 → $84 | -5.62% | Oct 7, 2024 |
Financial Forecast
Revenue This Year
28.26B
from 27.12B
Increased by 4.23%
Revenue Next Year
28.51B
from 28.26B
Increased by 0.87%
EPS This Year
3.91
from 4.50
Decreased by -13.22%
EPS Next Year
7.32
from 3.91
Increased by 87.56%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.0B | 30.5B | 31.8B | ||
| Avg | 28.3B | 28.5B | 29.4B | ||
| Low | 26.5B | 26.7B | 27.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.5% | 7.8% | 11.5% | ||
| Avg | 4.2% | 0.9% | 3.1% | ||
| Low | -2.3% | -5.4% | -4.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.16 | 8.39 | 8.89 | ||
| Avg | 3.91 | 7.32 | 7.80 | ||
| Low | 3.54 | 5.98 | 6.90 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -7.6% | 114.8% | 21.4% | ||
| Avg | -13.2% | 87.6% | 6.5% | ||
| Low | -21.4% | 53.1% | -5.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.